MDS-UPDRS scores remained stable and durable across overall study population after 150 days of treatment with ...

Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a ...

BOSTON, May 29, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare ...

Pharming’s Joenja receives European marketing authorization for the treatment of activated PI3K delta syndrome: Leiden, the Netherlands Tuesday, May 26, 2026, 13:00 Hrs [IST] Ph ...

All the details you need to follow the PAK vs AUS 1st ODI, including live streaming and TV broadcast information, match start ...

Apple has registered a new ‘gen AI’ sub domain which is expected to be a major hint at some of the new AI features that the ...

We’re now heading into Phase 3 of the Patriots offseason program. This week, we’ll get our first tangible look at the players ...

Broadcom eyes massive growth as new agreements de-risk its $100B AI revenue target despite OpenAI delays. See why AVGO stock ...

Q3 2026 Earnings Call May 28, 2026 1:00 PM EDTCompany ParticipantsGreg Watkin - Founder, Chairman of the Board, President ...

Sarah Cannon Research Institute (SCRI), one of the world's leading oncology research organizations conducting community-based clinical trials, will present new data across more than 155 abstracts and ...

Participants in Eli Lilly’s TRIUMPH-1 trial lost an average of roughly 85 pounds on the highest dose of retatrutide, an ...

Detailed price information for Excellon Resources Inc (EXN-X) from The Globe and Mail including charting and trades.